-
UroLife study fluid intake and micturition diary
A 4-day fluid and micturition diary was completed at 3 (n=1146) and 15 months (n=1000) after diagnosis. -
EATRIS-Plus multi-omics data of a human reference cohort
In this reference study, blood samples of 127 healthy individuals were analyzed with a wide range of -omics technologies. The profiling data set is publicly available. -
ReLife study blood samples
Serum and EDTA plasma samples were collected at 3 (n=335), 12 (n=266) and 24 months (n=237) after surgery. EDTA plasma samples have been analysed for CRP, IL-6, adiponectin, and... -
ReLife study accelerometer data
Accelerometer data (ActivPal) is available at 3 (n=346), 12 (n=323) and 24 months (n=271) after surgery. -
ReLife study food frequency questionnaire
A 163-item Food Frequency questionnaire was completed at 3 (n=352), 12 (n=330) and 24 months (n=275) after surgery. -
UroLife study molecular subtypes
Molecular subtype based on immunohistrochemistry performed on tissue microarrays is available for 389 T1 NMIBC tumours. -
UroLife study genome-wide germline SNP data
Isolated DNA and genome-wide germline SNP data is available for 1213 patients. -
POM imaging data
Imaging data of the Personalized Parkinson Project, including structural and functional MRI. -
Continuous Vital Parameters with Clinical Data of Patients Admitted to a...
Vital parameters measured with the VisiMobile (Sotera Wireless; San Diego, CA, USA) of inpatients at Radboudumc (Nijmegen, The Netherlands). The dataset records minute-by-minute... -
POM clinical data
Clinical data of the Personalized Parkinson Project, including motor scores, cognitive and neuropsychiatric assessments, autonomic symptoms, sleep and quality of life. -
The EuroTARGET cohort: A European project on TArgeted therapy in renal cell...
EuroTARGET is a European collaborative project designed as an observational study for which patients with mRCC were recruited prospectively in 62 centers. In total, 1,210... -
PRIDE Study obstetric records
Selected clinical data from obstetric records covering the pregnancy period and puerperium. Necessitates additional consent, provided by ~70% of participants -
UroLife study quality of life questionnaire
The EORTC QLQ-C30 and EORTC QLQ-NMIBC24 was completed at 6 weeks (n=1451) and 3 (n=1334), 15 (n=1159) and 51 months (n=588) after diagnosis. -
ReLife study quality of life questionnaire
The EORTC QLQ-C30 and EORTC QLQ-NMIBC24 was completed at 3 (n=365), 12 (n=317) and 24 months (n=279) after surgery. -
ReLife study general questionnaire
Patients with localized stage I-III renal cell cancer (n=365) completed paper-and-pencil or web-based questionnaires at 3 months (n=368), 12 months (n=317), and 24 months... -
PRIDE Study blood samples
First trimester blood samples (plasma, serum, whole blood) of ~1000 PRIDE Study participants, available for genetic and biochemical analyses. Stored at -80°C. -
PRIDE Study pharmacy data
Details on prescription medication fills in the three months before the last menstrual period until 6 months after the estimated date of delivery. Necessitates additional... -
ReLife study food frequency questionnaire
A 163-item Food Frequency questionnaire was completed at 3 (n=352), 12 (n=330) and 24 months (n=275) after surgery. -
PRIDE Study medication diaries
6-week medication diaries covering prescription and over-the counter use, administered in the second trimester of pregnancy. Available for 1516 PRIDE Study participants... -
ReLife study body composition data
CT-based assessment of body composition is available for n=349 patients.